The impact of secondary prevention strategies on the survival of carriers of the BRCA1 and BRCA2 pathogenic variants with luminal breast cancer who received no adjuvant chemotherapy is presented in Figure 1. The gene discussed is BRCA2; the disease is breast carcinoma.